Providers – ventricle-health

Your virtual partner in cardiac care

Our services are in addition to your care, and focus on close remote monitoring and expediting guideline-directed medical therapy for patients with heart failure and other conditions.

Your virtual partner in cardiac care

Our services are in addition to your care, and focus on close remote monitoring and expediting guideline-directed medical therapy for patients with heart failure and other conditions.

Virtually complementing your care

As a virtual network, we enhance your practice’s ability to see and treat patients by providing your eligible heart failure patients with a 4-month post-diagnosis program.

Boost patient outcomes and practice productivity

We provide fast access to optimal GDMT, helping your patients feel better while increasing your practice productivity.

Lower readmissions and mortality

70% lower readmissions for patients with HFrEF when on optimal GDMT1
8 years added to patient’s life on average by going from 2 to 4 GDMT medications2

Improved practice productivity

Reduce time spent on medication titration and authorizations
More capacity for new patients and in-person diagnostics and procedures

Our care model delivers results

Results from our pilot studies demonstrate improved outcomes, high satisfaction, and decreased healthcare utilization.1

High adherence

92%

appointment show rate

87%

recorded daily weight

High engagement

21pt

increase in KCCQ-12 score

99%

patient satisfaction

High impact

70pt

of appointments resulted in heart failure medication titration

90%

decrease in heart failure admissions in 4 months pre- vs. post-intervention

Our evidence-based care model addresses gaps in current clinical practice

Remote Monitoring for Heart Failure Management at Home: JACC Scientific Statement

“Early telemonitoring of weights and symptoms did not decrease heart failure hospitalizations... Remote monitoring coupled with a system of care that engages, informs, and empowers patients is essential for effective home management of heart failure to control symptoms, avoid hospitalization, and ameliorate the patient’s perception of illness.”

A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction

Optimizing to four GDMT medications reduces mortality by 70%

5 years increase in life expectancy when on optimal GDMT

Safety, Tolerability, and Efficacy of Up-Titration of Guideline-Directed Medical Therapies for Acute Heart Failure (STRONG-HF): A Multinational, Open-Label, Randomised Trial

Aggressive GDMT titration within weeks of heart failure discharge improves patient outcomes

34%

years increase in life expectancy when on optimal GDMT

Opportunities and Achievement of Medication Initiation Among Inpatients with Heart Failure with Reduced Ejection Fraction

Gaps remain in initiating evidence-based medications

1 in 3

visits to a cardiology clinic led to a GDMT addition or titration for heart failure patients

High patient satisfaction

Confidently refer your patients to Ventricle, knowing they’ll receive the highest quality care.

“They took very good care of me.
They were concerned about my health.”

—Ventricle patient

Partner with us

¹Bensimhon, D. (2024, March 4-6). High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT) [Conference session]. Technology and Heart Failure Therapeutics, Cardiovascular Research Foundation® (CRF®), Boston, MA, United States. https://www.tctmd.com/slide/high-frequency-virtual-cardiology-intervention-hf-vci-implementing-heart-failure-guideline ²Vaduganathan M, Docherty KF, Claggett BL, et al. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials [published correction appears in Lancet. 2023 Jan 14;401(10371):104. doi: 10.1016/S0140-6736(23)00018-1]. Lancet. 2022;400(10354):757-767. doi:10.1016/S0140-6736(22)01429-5